
Amgen Inc
NASDAQ:AMGN

Intrinsic Value
The intrinsic value of one
AMGN
stock under the Base Case scenario is
257.05
USD.
Compared to the current market price of 281.22 USD,
Amgen Inc
is
Overvalued by 9%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Amgen Inc
Fundamental Analysis
Want a deep‑dive on Amgen Inc?
Request it below and we’ll move it up the queue.

Revenue & Expenses Breakdown
Amgen Inc
Balance Sheet Decomposition
Amgen Inc
Current Assets | 29B |
Cash & Short-Term Investments | 12B |
Receivables | 6.8B |
Other Current Assets | 10.3B |
Non-Current Assets | 62.8B |
PP&E | 6.5B |
Intangibles | 46.3B |
Other Non-Current Assets | 9.9B |
Free Cash Flow Analysis
Amgen Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Amgen Inc
Revenue
|
33.4B
USD
|
Cost of Revenue
|
-12.9B
USD
|
Gross Profit
|
20.6B
USD
|
Operating Expenses
|
-13.3B
USD
|
Operating Income
|
7.3B
USD
|
Other Expenses
|
-3.2B
USD
|
Net Income
|
4.1B
USD
|
AMGN Profitability Score
Profitability Due Diligence
Amgen Inc's profitability score is 72/100. The higher the profitability score, the more profitable the company is.

Score
Amgen Inc's profitability score is 72/100. The higher the profitability score, the more profitable the company is.
AMGN Solvency Score
Solvency Due Diligence
Amgen Inc's solvency score is 24/100. The higher the solvency score, the more solvent the company is.

Score
Amgen Inc's solvency score is 24/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AMGN Price Targets Summary
Amgen Inc
According to Wall Street analysts, the average 1-year price target for
AMGN
is 328.48 USD
with a low forecast of 186.85 USD and a high forecast of 420 USD.
Dividends
Current shareholder yield for AMGN is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
AMGN
stock under the Base Case scenario is
257.05
USD.
Compared to the current market price of 281.22 USD,
Amgen Inc
is
Overvalued by 9%.